No CrossRef data available.
Article contents
The Power and Limits of Political Philosophy in Analyzing Healthcare Markets
Published online by Cambridge University Press: 31 January 2025
Extract
Bioethics is taking an institutional turn, where organizations are being taken seriously as moral agents. Within US healthcare, this is difficult to do without confronting “the market” as a highly influential context for organizational behavior. In the 1990s, pioneering thinkers such as David Mechanic,1 Brad Gray, and Mark Schlesinger2 undertook a first round of organizational ethics scholarship focused on how market forces influence health insurer behavior — motivated by a particular concern for health maintenance organizations (HMOs).3 And more recently, owing partly to a transfer of financial risk4 to healthcare delivery organizations,5 rapid consolidation within health system markets,6 and the pronounced uptick in physician employment,7 the behavior of healthcare delivery organizations is also being assessed in relation to market forces.
- Type
- Commentary
- Information
- Copyright
- © The Author(s), 2025. Published by Cambridge University Press on behalf of American Society of Law, Medicine & Ethics
References
Mechanic, D., Painful Choices: Research and Essays on Health Care (Transaction Publishers, 1989).Google Scholar
Schlesinger, M. et al., “Profit-Seeking, Corporate Control, and the Trustworthiness of Health Care Organizations: Assessments of Health Plan Performance by Their Affiliated Physicians,” Health Services Research 40, no. 3 (2005): 605–645, https://doi.org/10.1111/j.1475-6773.2005.00377.x.CrossRefGoogle ScholarPubMed
Fairbrother, G., Park, H.L., Haidery, A., and Gray, B.H., “Periods of Unmanaged Care in Medicaid Managed Care,” Journal of Health Care for the Poor and Underserved 16, no. 3 (2005): 444–452, https://doi.org/10.1353/hpu.2005.0049.CrossRefGoogle ScholarPubMed
Ellis, R. and McGuire, T., “Supply-Side and Demand-Side Cost Sharing in Health Care,” Journal of Economic Perspectives 7, no. 4 (1993): 135–52, https://doi.org/10.1257/jep.7.4.135.CrossRefGoogle ScholarPubMed
Tu, T., Muhlestein, D., Kocot, S.L., and White, R., The Impact of Accountable Care: Origins and Future of Accountable Care Organizations (Brookings Institution, 2015).Google Scholar
Dafny, L., “Addressing Consolidation in Health Care Markets,” JAMA 325, no. 10 (2021): 927–28, https://doi.org/10.1001/jama.2021.0038.CrossRefGoogle ScholarPubMed
See American Medical Association, AMA Examines a Decade of Change in Physician Practice Ownership and Employment, press release, July 12, 2023, https://www.ama-assn.org/press-center/press-releases/ama-examines-decade-change-physician-practice-ownership-and (last visited October 30, 2024).Google Scholar
Heath, J., Morality, Competition, and the Firm (Oxford University Press, 2014).CrossRefGoogle Scholar
Smith, A., The Theory of Moral Sentiments, ed. Haakonssen, K. (Cambridge University Press, 2002).CrossRefGoogle Scholar
MacIntyre, Ethics and Politics: Selected Essays
, Vol. II (Cambridge University Press, 2006).Google Scholar
Brill, S., America’s Bitter Pill: Money, Politics, Backroom Deals, and the Fight to Fix Our Broken Healthcare System (Random House, 2015).Google Scholar
Wouters, O.J., “Lobbying Expenditures and Campaign Contributions by the Pharmaceutical and Health Product Industry in the United States, 1999–2018,” JAMA Internal Medicine 180, no. 5 (2020): 688–697, https://doi.org/10.1001/jamainternmed.2020.0146.CrossRefGoogle ScholarPubMed